ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 735037 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 735037; 2) Community: the network communities that were significantly associated with the response to NSC 735037; 3) Molecule: the relationships between components within communities and NSC 735037; 4) MDR: the compounds that were significantly associated with the NSC 735037.

NSC Compound Enrichment Correlation
NSC 681639 Camptothecin Derivative 0.00134664791567076 0.83794151
NSC 697189 Null 0.00134664791567076 0.44956287
NSC 724998 MNR-2-50 0.00134664791567076 0.78254909
NSC 729813 6-(3-Aminopropyl)-5,6-dihydro-8,9-methylenedioxy-5,11-dioxo- 3-nitro-11H-indeno[1,2-c]isoquinoline Hydrochloride Salt 0.00134664791567076 0.74463706
NSC 305802 2,4-Quinazolinediamine, 5,6,7,8-tetrahydro-6-(2-naphthalenylsulfonyl)- 0.00162803849483079 0.31595561
NSC 56410 Porfiromycin 0.00162803849483079 0.6964169
NSC 624851 Null 0.00162803849483079 0.58786903
NSC 674103 2-Acetylimidazo[4,5-b]pyridin 4 p-chlorophenyl 3 thiosemicarbazone 0.00162803849483079 0.3169009
NSC 734949 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide 0.00162803849483079 0.21370728
NSC 746513 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole 0.0019098098157241 0.23958075
Total:91  Current:8    [First] [Prev] [Next] [Last]